Connection
David Schwartz to Biomarkers, Tumor
This is a "connection" page, showing publications David Schwartz has written about Biomarkers, Tumor.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.205 |
|
|
|
-
Levin M, Flor AC, Snyder H, Kron SJ, Schwartz D. UltraPlex Hapten-Based Multiplexed Fluorescent Immunohistochemistry. Methods Mol Biol. 2021; 2350:267-287.
Score: 0.105
-
Kern JA, Slebos RJ, Top B, Rodenhuis S, Lager D, Robinson RA, Weiner D, Schwartz DA. C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. J Clin Invest. 1994 Feb; 93(2):516-20.
Score: 0.065
-
Chu YH, Kobrossy B, Schwartz D, Bruns AD, Marsh J. Secretory Carcinoma of the Thyroid: A Case Report and Update of Literature. Head Neck Pathol. 2024 Sep 22; 18(1):84.
Score: 0.034